
Ajay Devgn faces new legal challenge over Vimal Elaichi notice as FDA asserts proceedings will continue
The story in brief
Ajay Devgn has challenged the Maharashtra FDA's notice over his Vimal Elaichi endorsement, arguing the action is arbitrary. The regulator insists proceedings will continue, citing concerns about surrogate promotion of banned products. The case is set for hearing on November 4, with the FDA's adjudication process ongoing.